Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug '25 Aug 12, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020
Market Capitalization	99	19	5	10	32	-
Market Cap Growth	963.85%	301.31%	-51.10%	-69.03%	-	-
Enterprise Value	94	21	5	7	35	-
Last Close Price	0.33	0.10	0.04	0.10	0.31	-
PS Ratio	112.71	20.73	10.91	23.60	69.52	-
PB Ratio	20.62	13.44	77.96	5.64	6.27	-
P/TBV Ratio	20.84	14.59	-	7.63	7.17	-
EV/Sales Ratio	107.43	22.25	10.89	17.31	75.54	-
Debt / Equity Ratio	-	0.15	40.56	0.05	0.03	-3.49
Asset Turnover	0.21	0.35	0.17	0.11	0.15	-
Quick Ratio	15.30	1.67	0.28	3.43	16.46	0.23
Current Ratio	15.53	2.42	0.36	3.51	16.49	0.50
Return on Equity (ROE)	-162.51%	-383.00%	-549.31%	-175.26%	-183.05%	-
Return on Assets (ROA)	-57.32%	-72.20%	-106.29%	-97.79%	-61.31%	-
Return on Capital (ROIC)	-77.90%	-91.27%	-123.94%	-104.75%	-64.86%	-
Earnings Yield	-5.76%	-25.43%	-111.71%	-60.66%	-13.98%	-
FCF Yield	-3.26%	-12.98%	-50.26%	-29.56%	-6.14%	-
Buyback Yield / Dilution	-39.61%	-45.63%	-6.98%	-38.82%	-396.41%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.